Council Members in this Study Group: 165
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
Harold Bays, MDPresident and Medical Director
L-MARC Research Center ![]()
Harold Bays, MD, FACP, FACE, is Medical Director and President of Louisville Metabolic and Atherosclerosis Research Center (L-MARC), a metabolic clinical research facility that has conducted over 400 phase I-IV clinical trials, including studies of all marketed lipid-altering drug treatments, as well...
Professor of Medicine
Finch University of Health Science-Chicago Medical School ![]()
Rohit Arora, MD, FACC, FAHA, FASCI, FACP, is Professor of Medicine and Professor of Physiology and Biophysics at Chicago Medical School. He is also the Chairman of Cardiology and Associate Chairman of Medicine in the Department of Medicine. Previously, he was Chief of Cardiology at UMDNJ and Director...
Cardiologist
NEW YORK UNIVERSITY (INC) ![]()
Daniel Fisher, MD, FACC, FACP, is a Cardiologist at NYU Medical Center. He has a private practice in Cardiology and specializes in non-invasive cardiology. Dr. Fisher is board certified in Internal Medicine, Cardiovascular Diseases, and Nuclear Cardiology. He has lectured frequently on such topicsas...
Hossein Ardehali, MD, PhDAssistant Professor
Northwestern University, Feinberg School of Medicine ![]()
Hossein Ardehali, MD, PhD, is an Assistant Professor of Medicine at Feinberg Cardiovascular Institute in Illinois. His specialties include lipid metabolism, preventive cardiology, electrophysiology and heart failure. Dr. Ardehali's basic science research interest is in the areas of reperfusion injury...
Clinical Director
NEW YORK UNIVERSITY (INC) ![]()
Howard Weintraub, MD, FACC, is the Clinical Director of Center for the Prevention of Cardiovascular Disease at NYU Medical Center. He has been a consultant for several organizations and has been a Cardiologist for the National Football League. Dr. Weintraub has written textbook chapters on evaluation...
Clinical Professor of Medicine
UNIVERSITY OF CALIFORNIA, LOS ANGELES ![]()
Dan Streja, MD, is a Clinical Professor of Medicine at the University of California, Los Angeles. He is Co-Director of the Lipid Clinic, the Cardiovascular Prevention Clinic and Diabetes Clinic, and the Divisions of Cardiology and Endocrinology at VA Medical Center of West Los Angeles. Dr. Streja has...
Director of Cardiac Catheterization Lab
Wadsworth VA Medical Center ![]()
Ramin Ebrahimi, MD, is Associate Clinical Professor at the University of California in Los Angeles. He is also Director of the Cardiac Catheterization Laboratory and Assistant Director of Nuclear Cardiology at the Wadsworth VA Medical Center. Dr. Ebrahimi’s clinical and research interests focus oninterventional...
Owner
JOSHUA M FEUER ![]()
Joshua Feuer, MD, FACC, is a board certified Cardiologist in solo private practice in Santa Barbara, California. He also serves as a Consulting Cardiologist at Santa Barbara Cottage Hospital. Dr. Feuer specializes in aggressive preventive cardiology and cardiovascular risk assessment and reduction....
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
September 30, 2009
Ronald Innerfield, MD, Vice President of Clinical Affairs, Evidence Based Medicine, Inc.
Controls to blood sugar 'cuts stroke risk' | www.barchester.com
There have been many epidemiologic studies showing a very tight correlation between baseline A1c and cardiovascular mortalityDespite this, five major randomized prospective studies have failed to show any macrovascular benefit for tighter glucose controlThe logical conclusion is that glucose is, therefore,...
July 20, 2009
FDA: Ongoing Omalizumab Study Shows Increased Number of Cardiovascular Events | www.docguide.com
Increased events likely from increased leukotrienes would be very hazardous as many smokers have lung and hear disease limiting its use in these situations.
Genetic Testing--ready for all of medicine or just a niche service?
January 12, 2009
Response Genetics, Inc. Signs Amendment to Its Master Service Agreement With GlaxoSmithKline (GSK) as Preferred Provider of Genetic Testing Services | www.devicespace.com
1. Article reports on the developing role of genetic testing in medicine 2. Also highlighted is the growing partnership of genetic testing firms with pharmaceutical industry 3. An area of interest is pharmacogenetics. There is individual response (or lack of response) to many drugs; this...
If it seems too good to be true...it probably is.
December 9, 2008
Joshua Feuer, MD, Owner, JOSHUA M FEUER
Generic Heart Drugs as Good as Brand-Name Counterparts | www.washingtonpost.com
This article implies that physician's have no justifiable reason for prescribing brand-name drugs. Unfortunately, it's not that simple.
December 8, 2008
Joshua Feuer, MD, Owner, JOSHUA M FEUER
There is a question of bias in this study. It is not prospective, not randomized and not blinded and thus no valid conclusions can be made. The study should be ignored. It will have no impact on sales.
Leading Experts in Cardiologists Specializing in Lipids (US) Study Group have not participated in any upcoming seminars.
View All GLG Live Meetings in Healthcare
Leading Experts in Cardiologists Specializing in Lipids (US) have not participated in any GLG webcasts.